TERUMO CORP revenue for the last year amounted to 921.86 B JPY, the most of which — 555.72 B JPY — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 480.61 B JPY. The greatest contribution to the revenue figure was made by United States — last year it brought TERUMO CORP 279.94 B JPY, and the year before that — 246.13 B JPY.